Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC

Update your browser to view ScienceDirect.

Request details:

Request ID: 8da6c82ade4522ae-LAX
IP: 47.97.18.252
UTC time: 2024-10-29T23:00:28+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4